The international law firm Greenberg Traurig, LLP has announced that
Eileen Smith Ewing has
joined its Boston office as
a Shareholder in the Corporate & Securities, Intellectual Property &
Technology, and Life Sciences Practice Groups. Prior to joining Greenberg
Traurig, Ewing was a Partner at Foley Hoag where she was Co-Chair of the Life
Science Practice Group.
"The addition of Eileen, who has more than 20 years of experience and is a
leader in the life sciences sector, to our Boston office further enhances our
corporate and securities and intellectual property capabilities in Massachusetts
and around the globe," said Gary Greenberg, Co-Managing Shareholder of Greenberg
Traurig’s Boston office. "Our Corporate and IP groups have experienced
significant growth in the past 18 months, and Eileen will complement our team
and expand the services we are able to provide our client-base."
will continue to focus her practice on representing life sciences companies in
their licensing deals and other IP-driven strategic alliances. Her transactional
practice ranges from traditional mergers, acquisitions, joint ventures, and
securities offerings to complex, cutting-edge research, development, and
commercialization agreements. Ewing has special experience in counseling public
and private pharmaceutical, biotechnology, and medical device companies on
raising the capital and structuring the industry partnerships needed to bring a
health care product to market.
Comprised of 350 lawyers in more than 30 offices, Greenberg Traurig's
Corporate and Securities/M&A Practice has been recognized by numerous
business and legal publications including Chambers and Partners Global and USA
guides, The American Lawyer's "Corporate Scorecard" and The Legal 500 -
Corporate and Finance section, U.S. edition.
Consistently ranked among
the Top 10 law firms by IPLaw 360, IP Law & Business and CSC Trademark
Insider as the most frequently hired patent and trademark practices for
prosecution and litigation, Greenberg Traurig’s Intellectual Property &
Technology Practice brings together more than 200 attorneys with experience
encompassing an array of industries and technologies, including biotechnology,
consumer products, digital media, electronics, entertainment, fashion, financial
services, industrial products, medical devices, metallurgy, nanotechnology,
pharmaceuticals and software.
A frequent industry speaker and the author of more than 35 publications in
her field, Ewing also speaks Japanese and has significant experience in Pacific
Rim business matters. A Fellow of the American Bar Foundation, she chairs
the American Bar Association's Committee on Biotechnology and is chair-elect of
its Life Sciences Division, and she serves on the Leadership Council of the
ABA's Section of Science & Technology Law.
Ewing holds a J.D. from Columbia Law School and an A.B. from Harvard
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an
international, full-service law firm with approximately 1,800 attorneys serving
clients from more than 30 offices in the United States, Europe and Asia. In the
U.S., the firm has more offices than any other among the Top 10 on The National
Law Journal’s 2011 NLJ 250. In the U.K., the firm operates as Greenberg Traurig Maher LLP.
Greenberg Traurig has a strategic alliance with the independent law firm, Studio
Santa Maria in Milan and Rome. The firm was Chambers and Partners' USA Law Firm
of the Year in 2007 and among the Top 3 in the International Law Firm of the
Year at the 2009 The Lawyer Awards. For additional information, please visit www.gtlaw.com.